[1. Hulsmeyer M, Hillig RC, Volz A, Ruhl M, Schroder W, Saengen W, et al. HLA-B27 Subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem. 2002; 227(49): 47844-47853.10.1074/jbc.M20639220012244049]Search in Google Scholar
[2. Popa OM, Bojinica M, Bojinica V, Ciofu C, Dutescu MI, Bardan A, et al.Distribution of HLAB27 in Romanian spondyloarthritides patients. Int J Immunogenet. 2010; 37(6): 513-516.10.1111/j.1744-313X.2010.00945.x20572892]Search in Google Scholar
[3. Colbert RA, DeLay ML, Layh-Schmitt G, Sowders DP. HLA-B27 misfolding and spondyloarthropathies. Prion. 2009; 3(1): 15-26.10.4161/pri.3.1.8072267673919363299]Search in Google Scholar
[4. Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology. 2002; 41(8): 857-868.10.1093/rheumatology/41.8.85712154202]Search in Google Scholar
[5. Huhtinen M. Acute anterior uveitis and HLAB27: infectious background, systemic inflamation and prognosis of the patients. Academic dissertation, defended at the Medical Faculty of the University of Helsinki, Helsinki, 2002.]Search in Google Scholar
[6. Allen RL, Bowness P, McMichael AJ. The role of HLA-B27 in spondyloarthritis. Immunogenetics. 1999; 50(3-4): 220-227.10.1007/s00251005059610602882]Search in Google Scholar
[7. Marsh SGE. Nomenclature for factors of the HLA system, update September 2011. Int J Immunogenet. 2011; 39(1): 95-97.10.1111/j.1744-313X.2011.01056.x]Search in Google Scholar
[8. Khan MA. Recent advances in the genetics of ankylosing spondylitis. Future Rheumatol. 2008; 3(5): 403-405.10.2217/17460816.3.5.403]Search in Google Scholar
[9. Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bitti P, et al. Increased level of HLA B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology. 2002; 41(12): 1375-1379.10.1093/rheumatology/41.12.137512468816]Search in Google Scholar
[10. Vartdal F, Gaudernack G, Funderud S, Bratlie A, Lea T, Ugelstad J, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation-a fast and reliable technique. Tissue Antigens. 1986; 25(5): 301-312.10.1111/j.1399-0039.1986.tb00500.x3469787]Search in Google Scholar
[11. Vartdal F, Bratlie A, Gaudernack G, Funderud S, Lea T, Thorsby E. Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres. Transplant Proceedings. 1987; 19(1): 655-657.]Search in Google Scholar
[12. Walker RH. Technical Manual, 11th ed. Bethesda: American Association of Blood Banks, 1993: 305-307.]Search in Google Scholar
[13. Stites DP, Stobo JD, Wells JV. Osnovna i klinička imunologija. Beograd: Savremena Administracija, 1989; 50-63.]Search in Google Scholar
[14. Svejgaard A, Platz R, Ryder LP. HLA and disease 1982-A survey. Immunolog Rev. 1983; 70(1): 193-201.10.1111/j.1600-065X.1983.tb00715.x6339368]Search in Google Scholar
[15. Bengston BO, Thompson G. Measuring the strength of associations between HLA antigens and disease. Tissue Antigens. 1981; 18(5): 356-363.10.1111/j.1399-0039.1981.tb01404.x7344182]Search in Google Scholar
[16. Green A. The epidemiologic approach to studies of association between HLA and disease.II Estimation of absolute risk, etiologic and preventive fraction. Tissue Antigens. 1982; 19(4): 259-168.10.1111/j.1399-0039.1982.tb01450.x7101270]Search in Google Scholar
[17. Petz B. Osnovne statističke metode. Zagreb: Izdanja škole narodnog zdravlja “Andrija Štampar.” 1967: 111-134.]Search in Google Scholar
[18. Snedecor GW, Cochan GW. Statistical Methods. Ames: The Iowa State University Press. 1956: 219-221.]Search in Google Scholar
[19. Emam SJ, Badri S, Bayat A, Dashtebozorg N, Khosravi A. Evaluation of 278 HLA-B27 positive patients suspected of seronegative spondyloarthropathies. Pakistan J Med Sci. 2007; 23(5): 728-732.]Search in Google Scholar
[20. McMichael A, Bowness P. HLA-B27:natural function and pathogenic role in spondyloarthritis. Arthritis Res. 2002; 4(Suppl 3): S153-S158.10.1186/ar571324014712110134]Search in Google Scholar
[21. Sahin S, Aydogan L, Benli I, Ozyurt H. Distribution of HLA-B27 and CYP2D6*4 mutations in the middle Black Sea area (Tokat) of Turkey. Genet Molec Res. 2011; 10(4): 3987-3991.10.4238/2011.December.2.322180068]Search in Google Scholar
[22. Sheehan NJ. The ramifications of HLA-B27. J Roy Soc Med. 2004; 97(1): 10-14.10.1177/014107680409700102]Search in Google Scholar
[23. Dhurandhar PS, Shankarkumar U. HLA Association in seronegative spondyloarthritis patients from Mumbai, India. Int J Hum Genet. 2007; 7(3): 235-239.10.1080/09723757.2007.11886000]Search in Google Scholar
[24. Pitchappan RM, Balakrlshnan K, Mahendran V, Brahmajathi V. HLA and disease susceptibility in Tamil Nadu, S. India. Indian J Hum Genet. 1995; 1(1):56-62.]Search in Google Scholar
[25. Kim T-H, Uhm W-S, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol. 2005; 17(4): 400-405.10.1097/01.bor.0000163447.44037.c415956835]Search in Google Scholar
[26. Colmegna I, Cuchacovich R, Espinoza LR. HLA- B27 associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004; 17(2): 348-369.10.1128/CMR.17.2.348-369.200438740515084505]Search in Google Scholar
[27. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheumatic Dis Clin North Am. 2009; 35(1): 21-44.10.1016/j.rdc.2009.03.01019480995]Search in Google Scholar
[28. FitzGerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther. 2009; 11(1): 214-223.10.1186/ar2580268822919232079]Search in Google Scholar
[29. Khairallah M,Yahia SB, Ladjimi A, Messaoud R, Zaouali S, Attia S, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye. 2007; 21(1): 33-39.10.1038/sj.eye.670211116215541]Search in Google Scholar
[30. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27: what’s new? In: Pleyer U, Forrester JV, Eds. Uveitis and Immunological Disorders. Heidelberg: Springer- Verlag. 2009:9-17.10.1007/978-3-540-69459-5_2]Search in Google Scholar
[31. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Survey Ophtalmol. 2005; 50(4): 364-388.10.1016/j.survophthal.2005.04.00315967191]Search in Google Scholar
[32. Mishra MN, Bharucha KM. HLA-B27 Association with uveitis in an Asian Indian population. Iranian J Immunol. 2011; 8(2): 85-89.]Search in Google Scholar